Monday, 23 September 2013

Recommendations guide physicians in treatment of systemic juvenile arthritis




In the U.S., there are nearly 300,000 children with juvenile arthritis and other rheumatic illnesses according to estimates from the American College of Rheumatology (ACR). For pediatric patients with systemic juvenile idiopathic arthritis (JIA), effective treatment for this disabling disease is imperative. New treatment recommendations that guide physicians caring for children with systemic JIA are now published in the ACR journals, Arthritis & Rheumatism and Arthritis Care & Research.


Systemic JIA is defined by the International League of Associations for Rheumatology as arthritis in one or more joints for at least six weeks in children sixteen years of age or younger. The is accompanied or preceded by fever for at least two-weeks that is daily ("quotidian") for at least 3 of those days, with one or more of the following symptoms: red rash (evanescent erythematous rash), enlarged liver, spleen or lymph nodes, and inflammation of the tissue lining (serositis) of the lungs, heart, or stomach. Medical evidence suggests that systemic JIA accounts for 4% to 15% of all JIA cases.


Each year the ACR reviews its current guidelines to ensure that they are up to date. In 2012, the ACR determined that an update to the 2011 JIA recommendations—specifically for treatment of systemic JIA—was needed. A new team that included researchers who worked on the original JIA guideline was assembled to develop the 2013 update. Investigators, led by Dr. Pamela Weiss from Children's Hospital of Philadelphia in Pennsylvania and Dr. Sarah Ringold from the Seattle Children's Hospital in Washington, conducted a systematic review of medical literature through January 2013.


The new recommendations for systemic JIA are based upon more than 1,200 clinical scenarios and include recommendations for use of the following medications:



  • Non-steroidal anti-inflammatory drugs (NSAIDs)

  • Glucocorticoids

  • Methotrexate

  • Leflunomide

  • Intravenous immunoglobulin (IVIG)

  • Calcineurin inhibitors

  • Tumor necrosis factor alpha (TNF?) inhibitors

  • Abatacept

  • Rituximab

  • Anakinra

  • Canakinumab *

  • Rilonacept *

  • Tocilizumab *


They include treatment options for patients with and without active systemic disease, along with varying degrees of inflammation of the joint lining (synovitis), as well as recommendations for repeat TB screening for JIA patients receiving biologics. Dr. Weiss concludes, "The 2013 recommendations address specific disease characteristics and reflect the commitment to enhancing care of children with systemic JIA."


*New addition to the 2013 update


More information: "2013 Update of the 2011 American College of Rheumatology Recommendations for the Treatment of Juvenile Idiopathic Arthritis. Recommendations for the Medical Therapy of Children with Systemic Juvenile Idiopathic Arthritis and Tuberculosis Screening Among Children Receiving Biologic Medications." Sarah Ringold, Pamela F. Weiss, Timothy Beukelman, Esi Morgan DeWitt, Norman T. Ilowite, Yukiko Kimura, Ronald M. Laxer, Daniel J. Lovell, Peter A. Nigrovic, Angela Byun Robinson and Richard K. Vehe. Arthritis & Rheumatism (DOI: 10.1002/art.38092). Arthritis Care & Research (DOI: 10.1002/acr.22087); Published Online: September 24, 2013.


Medical Xpress on facebook

Related Stories


New clinical practice guidelines developed for juvenile idiopathic arthritis


Mar 30, 2011



The American College of Rheumatology has developed new guidelines for starting and monitoring treatments for children with juvenile idiopathic arthritis. These are the first JIA guidelines endorsed by the ACR, with the goal ...



Children with juvenile arthritis have higher rates of bacterial infection


May 01, 2012



Children with juvenile idiopathic arthritis (JIA) have higher rates of hospitalized bacterial infection than children without JIA according to an observational study appearing in Arthritis & Rheumatism, a journal published by Wil ...



Standardized treatment plans developed for new-onset JIA


Jul 03, 2012



(HealthDay) -- Four standardized consensus treatment plans (CTPs) have been developed for patients with new-onset systemic juvenile idiopathic arthritis (JIA), according to research published in the July issue ...



The Medical Minute: What juvenile idiopathic arthritis means for kids


Jul 31, 2012



July is Juvenile Arthritis Awareness month, and a great opportunity to learn about a disease that you may not have much exposure to, or perhaps a chance to learn more about a condition that affects a friend or family member.



Juvenile arthritis patients may have issues maintaining employment as adults


May 31, 2012



As children with juvenile idiopathic arthritis (JIA) grow into adulthood, disability due to disease may adversely affect their ability to achieve educational success. Findings published in Arthritis & Rheumatism, a journa ...



Recommended for you


New method of identifying people at high risk of developing rheumatoid arthritis


Sep 20, 2013



(Medical Xpress)—Researchers at The University of Manchester and King's College London, funded by Arthritis Research UK, have developed a new method to identify people that are at a very high-risk of developing rheumatoid ...



Study upholds hyaluronic acid injection safety, efficacy profile in reducing knee OA pain


Sep 17, 2013



A new meta-analysis of 29 randomized studies involving more than 4,500 patients with knee osteoarthritis (OA) found that intra-articular hyaluronic acid (HA) injections provided significant improvement in pain and function ...



Copper bracelets and magnetic wrist straps fail to help rheumatoid arthritis, research says


Sep 16, 2013



Copper bracelets and magnet wrist straps have no real effect on pain, swelling, or disease progression in rheumatoid arthritis, according to new findings from a study conducted at the University of York.



New scoring system predicts likelihood of diabetes remission after weight-loss surgery


Sep 12, 2013



US scientists have developed a simple scoring system (DiaRem), based on four readily available preoperative patient characteristics, that can predict which candidates for gastric bypass surgery are likely to achieve diabetes ...



Bacteria responsible for gum disease facilitates rheumatoid arthritis


Sep 12, 2013



Does gum disease indicate future joint problems? Although researchers and clinicians have long known about an association between two prevalent chronic inflammatory diseases - periodontal disease and rheumatoid arthritis ...





Scientists find genetic link between sugary drinks and gout


Sep 12, 2013



(Medical Xpress)—University of Otago and Auckland scientists have for the first time discovered a human gene variant that can "turn bad" when affected by sugary drinks, raising the risk of developing the ...



User comments








In the U.S., there are nearly 300,000 children with juvenile arthritis and other rheumatic illnesses according to estimates from the American College of Rheumatology (ACR). For pediatric patients with systemic juvenile idiopathic arthritis (JIA), effective treatment for this disabling disease is imperative. New treatment recommendations that guide physicians caring for children with systemic JIA are now published in the ACR journals, Arthritis & Rheumatism and Arthritis Care & Research.


Systemic JIA is defined by the International League of Associations for Rheumatology as arthritis in one or more joints for at least six weeks in children sixteen years of age or younger. The is accompanied or preceded by fever for at least two-weeks that is daily ("quotidian") for at least 3 of those days, with one or more of the following symptoms: red rash (evanescent erythematous rash), enlarged liver, spleen or lymph nodes, and inflammation of the tissue lining (serositis) of the lungs, heart, or stomach. Medical evidence suggests that systemic JIA accounts for 4% to 15% of all JIA cases.


Each year the ACR reviews its current guidelines to ensure that they are up to date. In 2012, the ACR determined that an update to the 2011 JIA recommendations—specifically for treatment of systemic JIA—was needed. A new team that included researchers who worked on the original JIA guideline was assembled to develop the 2013 update. Investigators, led by Dr. Pamela Weiss from Children's Hospital of Philadelphia in Pennsylvania and Dr. Sarah Ringold from the Seattle Children's Hospital in Washington, conducted a systematic review of medical literature through January 2013.


The new recommendations for systemic JIA are based upon more than 1,200 clinical scenarios and include recommendations for use of the following medications:



  • Non-steroidal anti-inflammatory drugs (NSAIDs)

  • Glucocorticoids

  • Methotrexate

  • Leflunomide

  • Intravenous immunoglobulin (IVIG)

  • Calcineurin inhibitors

  • Tumor necrosis factor alpha (TNF?) inhibitors

  • Abatacept

  • Rituximab

  • Anakinra

  • Canakinumab *

  • Rilonacept *

  • Tocilizumab *


They include treatment options for patients with and without active systemic disease, along with varying degrees of inflammation of the joint lining (synovitis), as well as recommendations for repeat TB screening for JIA patients receiving biologics. Dr. Weiss concludes, "The 2013 recommendations address specific disease characteristics and reflect the commitment to enhancing care of children with systemic JIA."


*New addition to the 2013 update


More information: "2013 Update of the 2011 American College of Rheumatology Recommendations for the Treatment of Juvenile Idiopathic Arthritis. Recommendations for the Medical Therapy of Children with Systemic Juvenile Idiopathic Arthritis and Tuberculosis Screening Among Children Receiving Biologic Medications." Sarah Ringold, Pamela F. Weiss, Timothy Beukelman, Esi Morgan DeWitt, Norman T. Ilowite, Yukiko Kimura, Ronald M. Laxer, Daniel J. Lovell, Peter A. Nigrovic, Angela Byun Robinson and Richard K. Vehe. Arthritis & Rheumatism (DOI: 10.1002/art.38092). Arthritis Care & Research (DOI: 10.1002/acr.22087); Published Online: September 24, 2013.


Medical Xpress on facebook

Related Stories


New clinical practice guidelines developed for juvenile idiopathic arthritis


Mar 30, 2011



The American College of Rheumatology has developed new guidelines for starting and monitoring treatments for children with juvenile idiopathic arthritis. These are the first JIA guidelines endorsed by the ACR, with the goal ...



Children with juvenile arthritis have higher rates of bacterial infection


May 01, 2012



Children with juvenile idiopathic arthritis (JIA) have higher rates of hospitalized bacterial infection than children without JIA according to an observational study appearing in Arthritis & Rheumatism, a journal published by Wil ...



Standardized treatment plans developed for new-onset JIA


Jul 03, 2012



(HealthDay) -- Four standardized consensus treatment plans (CTPs) have been developed for patients with new-onset systemic juvenile idiopathic arthritis (JIA), according to research published in the July issue ...



The Medical Minute: What juvenile idiopathic arthritis means for kids


Jul 31, 2012



July is Juvenile Arthritis Awareness month, and a great opportunity to learn about a disease that you may not have much exposure to, or perhaps a chance to learn more about a condition that affects a friend or family member.



Juvenile arthritis patients may have issues maintaining employment as adults


May 31, 2012



As children with juvenile idiopathic arthritis (JIA) grow into adulthood, disability due to disease may adversely affect their ability to achieve educational success. Findings published in Arthritis & Rheumatism, a journa ...



Recommended for you


New method of identifying people at high risk of developing rheumatoid arthritis


Sep 20, 2013



(Medical Xpress)—Researchers at The University of Manchester and King's College London, funded by Arthritis Research UK, have developed a new method to identify people that are at a very high-risk of developing rheumatoid ...



Study upholds hyaluronic acid injection safety, efficacy profile in reducing knee OA pain


Sep 17, 2013



A new meta-analysis of 29 randomized studies involving more than 4,500 patients with knee osteoarthritis (OA) found that intra-articular hyaluronic acid (HA) injections provided significant improvement in pain and function ...



Copper bracelets and magnetic wrist straps fail to help rheumatoid arthritis, research says


Sep 16, 2013



Copper bracelets and magnet wrist straps have no real effect on pain, swelling, or disease progression in rheumatoid arthritis, according to new findings from a study conducted at the University of York.



New scoring system predicts likelihood of diabetes remission after weight-loss surgery


Sep 12, 2013



US scientists have developed a simple scoring system (DiaRem), based on four readily available preoperative patient characteristics, that can predict which candidates for gastric bypass surgery are likely to achieve diabetes ...



Bacteria responsible for gum disease facilitates rheumatoid arthritis


Sep 12, 2013



Does gum disease indicate future joint problems? Although researchers and clinicians have long known about an association between two prevalent chronic inflammatory diseases - periodontal disease and rheumatoid arthritis ...





Scientists find genetic link between sugary drinks and gout


Sep 12, 2013



(Medical Xpress)—University of Otago and Auckland scientists have for the first time discovered a human gene variant that can "turn bad" when affected by sugary drinks, raising the risk of developing the ...



User comments








Categories:

0 comments:

Post a Comment